TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

Pallawi Torka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.